Caitong International Asset Management Co., LTD Ionis Pharmaceuticals Inc Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 28 shares of IONS stock, worth $1,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 3
833.33%
Holding current value
$1,114
Previous $105,000
704.76%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$652 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$644 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$492 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$411 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$335 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.65B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...